phosphotyrosine has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbhuiya, MA; Chatterjee, A; Datta, KK; Gowda, H; Khan, AA; Kumar, MV; Kumar, RV; Nirujogi, RS; Pandey, A; Pinto, SM; Prasad, TS; Renuse, S; Srikumar, K; Syed, N | 1 |
1 other study(ies) available for phosphotyrosine and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Ephrin-A2; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Mass Spectrometry; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Signal Transduction | 2015 |